Federal agents arrested a Chicago daycare worker just after the center opened Wednesday in a scene city officials said unfolded in front of teachers, parents and children. City officials and parents ...
Nov. 1 is the solemnity of All Saints — known more popularly as All Saints’ Day — the day on which the Catholic Church celebrates all who have attained eternal life with God in heaven. The Catholic ...
BOSTON--(BUSINESS WIRE)--Method AI, a medical technology company focused on improving oncology outcomes through image-guided surgical navigation, announced today it has raised $20 million in Series A ...
NESS ZIONA, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. , a dermatology company, pioneering treatments for patients with severe skin conditions, conducting a Phase-3 clinical ...
Christy Bieber has a JD from UCLA School of Law and began her career as a college instructor and textbook author. She has been writing full time for over a decade with a focus on making financial and ...
It's all well and good investing your hard-earned money into a swanky new set of gel nails (courtesy of your fave highstreet salon), but when it comes to the end of your manis' shelf-life, if you're ...
DIY fun only! Not a pro; always use PPE (gloves!). Full disclaimer below. Hey besties! Join me as I remove my Gel X nails using the soak-off method. It's easier than you think! We'll prep the remover, ...
SOL Strategies, a Canadian public company focused on Solana infrastructure, reported a net loss in the second quarter even as revenue from staking and validating surged. The company, which trades on ...
A threshold matter for determining the proper procedure during an exam is whether a potentially identified issue is an accounting method (a timing issue, as discussed ...
Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for Gorlin syndrome and extending cash runway to 2027. Sol-Gel Technologies, Ltd. has announced a product purchase ...
Sol-Gel to receive $16 million during 2025 Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient cash to complete its Phase III clinical trial SGT-610 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results